pasireotide has been researched along with Endocrine-System-Diseases* in 1 studies
1 other study(ies) available for pasireotide and Endocrine-System-Diseases
| Article | Year |
|---|---|
Preclinical evidences suggest new treatment options for endocrine disorders: Pasireotide (SOM230) and Everolimus (RAD001).
Topics: Animals; Endocrine System Diseases; Everolimus; Humans; Immunosuppressive Agents; Oligopeptides; Protein Kinases; Receptors, Somatostatin; Sirolimus; Somatostatin; TOR Serine-Threonine Kinases | 2008 |